Document is current
Any future updates will be listed below
-
Authors
Langer-Gould, Annette M. https://orcid.org/0000-0001-6891-7147
Cepon-Robins, Tara J.
Benn Torres, Jada https://orcid.org/0000-0001-9678-4038
Yeh, E. Ann
Gildner, Theresa E.
- License Information
-
More Information
Article History
Accepted: 28 April 2025
First Online: 27 May 2025
Competing interests
: A.M.L.-G. has received grant support and awards from the Patient-Centered Outcomes Research Institute, the National Multiple Sclerosis Society and Atara Biotherapeutics. She currently serves as a voting member on the California Technology Assessment Forum, a core programme of the Institute for Clinical and Economic Review. E.A.Y. has received payments from Hoffman-LaRoche, Alexion (advisory boards) and Pipeline Therapeutics (Data Safety and Monitoring Board) and research funding from Biogen, the National Multiple Sclerosis Society, the Consortium of Multiple Sclerosis Centers, the Canadian Institutes of Health Research, the National Instiututes of Health, the Ontario Institute for Regenerative Medicine, the Stem Cell Network, Garry Hurvitz Centre for Brain & Mental Health Chase an Idea, the SickKids Foundation, the Rare Diseases Foundation, the Multiple Sclerosis Scientific Research Foundation, Canada’s Drug Agency, the McLaughlin Centre, the Leong Center, the Peterson Foundation and the Centre for Brain & Mental Health, and is Co-Editor in Chief of Multiple Sclerosis and Related Disorders. T.J.C.-R., J.B.T. and T.E.G. declare no competing interests.
